Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation
复制标题
DOI：
10.1016/s0041-1345(03)00009-5
复制
发表时间：
2003-03-01
影响因子：
0.9
通讯作者：
Tur-Kaspa, R
中科院分区：
文献类型：
--
作者：
Ben-Ari, Z;Mor, E;Tur-Kaspa, R
RESULTSMean follow-up period was 55.4 35.2 months for group 1 and 26.6 23.4 months for group 2 (the difference in duration of follow-up was due to the later introduction of tacrolimus). The baseline characteristics of the 2 groups, as shown in Table 1, reveal no statistically significant differences in age, sex, and rate of HCC diagnosis before transplantation, although the rate was numerically higher in group 2 (15.7% vs 0% in group 1). There were no differences in pretransplantation alcohol abuse, number of acute rejection episodes, CMV antigenemia, diabetes mellitus, and serum creatinine level. However, OKT3 administration for refractory acute rejection episodes occurred signifi-
